Pancreatic Cancer Research

ResearcherChina Pharmaceutical UniversityActive in the last 2 years

Xinyuan Zhou

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-1374-8240; OpenAlex author ID A5025214572. Sources: OpenAlex.

Their work

Papers
3 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2022: 1 paper · 2023: 1 paper · 2024: none · 2025: 1 paper

Papers 3

  1. Identification and validation of prognostic biomarkers related to tumor immune invasion in pancreatic cancer. First author DOI 10.3389/fgene.2025.1556544↗
  2. Enhancing chemotherapy for pancreatic cancer through efficient and sustained tumor microenvironment remodeling with a fibroblast-targeted nanosystem. Co-author DOI 10.1016/j.jconrel.2023.07.061↗
  3. Insulin receptor tyrosine kinase substrate (IRTKS) promotes the tumorigenesis of pancreatic cancer via PI3K/AKT signaling. First author DOI 10.1007/s13577-022-00770-w↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Chen Wang · 1 shared paper, 2025 · strength 0.33
  2. Minxue Chen · 1 shared paper, 2025 · strength 0.33
  3. Wei Xu · 1 shared paper, 2023 · strength 0.20
  4. Meirong Huo · 1 shared paper, 2023 · strength 0.20
  5. Yu Lu · 1 shared paper, 2022 · strength 0.17
  6. Chen Wang · 1 shared paper, 2022 · strength 0.17
  7. Jie Liu · 1 shared paper, 2022 · strength 0.17

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.